What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Myocardial infarction
- Surgery
The scientist’s investigation covers issues in Internal medicine, Cardiology, Myocardial infarction, Surgery and Atrial fibrillation.
His study looks at the relationship between Internal medicine and fields such as Anesthesia, as well as how they intersect with chemical problems.
His studies link Platelet aggregation inhibitor with Cardiology.
The concepts of his Atrial fibrillation study are interwoven with issues in Stroke, Antithrombotic and Anticoagulant.
Freek W.A. Verheugt interconnects Stent and Conventional PCI in the investigation of issues within Percutaneous coronary intervention.
His Randomized controlled trial research includes elements of Clinical trial and MEDLINE.
His most cited work include:
- ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008 (3307 citations)
- 2012 focused update of the ESC Guidelines for the management of atrial fibrillation (2409 citations)
- Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology. (2080 citations)
What are the main themes of his work throughout his whole career to date?
Freek W.A. Verheugt mostly deals with Internal medicine, Cardiology, Myocardial infarction, Atrial fibrillation and Surgery.
His study on Aspirin, Stroke, Percutaneous coronary intervention and Acute coronary syndrome is often connected to In patient as part of broader study in Internal medicine.
His biological study spans a wide range of topics, including Platelet aggregation inhibitor and Conventional PCI.
His Myocardial infarction study combines topics from a wide range of disciplines, such as Artery and Fibrinolysis.
His work deals with themes such as Anticoagulant and Anesthesia, which intersect with Atrial fibrillation.
His research integrates issues of Intensive care medicine and Antithrombotic in his study of Surgery.
He most often published in these fields:
- Internal medicine (69.89%)
- Cardiology (53.23%)
- Myocardial infarction (28.14%)
What were the highlights of his more recent work (between 2015-2021)?
- Internal medicine (69.89%)
- Cardiology (53.23%)
- Atrial fibrillation (21.68%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Internal medicine, Cardiology, Atrial fibrillation, Stroke and Percutaneous coronary intervention.
His Myocardial infarction, Acute coronary syndrome, Coronary artery disease and Antithrombotic study in the realm of Internal medicine connects with subjects such as In patient.
His Cardiology research focuses on subjects like Chronic fatigue syndrome, which are linked to Orthostatic intolerance.
His Atrial fibrillation research includes themes of Anticoagulant and Cohort.
His research in Stroke tackles topics such as Intensive care medicine which are related to areas like Oral anticoagulation.
His Percutaneous coronary intervention study combines topics in areas such as Anesthesia, Randomized controlled trial, Surgery, Conventional PCI and Aspirin.
Between 2015 and 2021, his most popular works were:
- 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). (1195 citations)
- Prevention of Bleeding in Patients with Atrial Fibrillation Undergoing PCI (788 citations)
- Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial (259 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Myocardial infarction
- Surgery
His primary scientific interests are in Internal medicine, Atrial fibrillation, Stroke, Percutaneous coronary intervention and Cardiology.
His work on Antithrombotic, Coronary artery disease, Myocardial infarction and Heart failure as part of general Internal medicine research is frequently linked to In patient, thereby connecting diverse disciplines of science.
The study incorporates disciplines such as Embolism, Cohort and Intensive care medicine in addition to Atrial fibrillation.
Freek W.A. Verheugt has researched Stroke in several fields, including Anticoagulant, Prospective cohort study, Clinical trial and Kidney disease.
His Percutaneous coronary intervention research is multidisciplinary, incorporating perspectives in Stent, Surgery, Conventional PCI and Acute coronary syndrome.
Freek W.A. Verheugt studies Cardiology, focusing on Transcranial Doppler in particular.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
